2qpj: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="2qpj" size="350" color="white" frame="true" align="right" spinBox="true" caption="2qpj, resolution 2.05Å" /> '''Human NEP complexed ...
 
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic, inactivation of a number of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin and atrial natriuretic factor, as well, as the incretin hormone glucagon-like peptide 1 (GLP-1), which is a potent, stimulator of insulin secretion. The activity of GLP-1 is also rapidly, abolished by the serine protease dipeptidyl peptidase IV (DPP-IV), which, led to an elevated interest in inhibitors of this enzyme for the treatment, of type II diabetes. A dual NEP/DPP-IV inhibitor concept is proposed, offering an alternative strategy for the treatment of type 2 diabetes., Here, the synthesis and crystal structures of the soluble extracellular, domain of human NEP (residues 52-749) complexed with the NEP, competitive, and potent dual NEP/DPP-IV inhibitor MCB3937 are described.
Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic inactivation of a number of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin and atrial natriuretic factor, as well as the incretin hormone glucagon-like peptide 1 (GLP-1), which is a potent stimulator of insulin secretion. The activity of GLP-1 is also rapidly abolished by the serine protease dipeptidyl peptidase IV (DPP-IV), which led to an elevated interest in inhibitors of this enzyme for the treatment of type II diabetes. A dual NEP/DPP-IV inhibitor concept is proposed, offering an alternative strategy for the treatment of type 2 diabetes. Here, the synthesis and crystal structures of the soluble extracellular domain of human NEP (residues 52-749) complexed with the NEP, competitive and potent dual NEP/DPP-IV inhibitor MCB3937 are described.


==About this Structure==
==About this Structure==
Line 14: Line 14:
[[Category: Neprilysin]]
[[Category: Neprilysin]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Dale, G.E.]]
[[Category: Dale, G E.]]
[[Category: Oefner, C.]]
[[Category: Oefner, C.]]
[[Category: I20]]
[[Category: I20]]
Line 28: Line 28:
[[Category: zinc-dependent metalloprotease]]
[[Category: zinc-dependent metalloprotease]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 11:59:17 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:41:10 2008''